Sugammadex Versus Neostigmine Use in Patients Undergoing Septoplasty Operations

NCT02026999 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 88

Last updated 2014-01-03

No results posted yet for this study

Summary

The purpose of this study to determine the effectiveness of sugammadex in septoplasty patients whose mask ventilation would be difficult after extubation.

Conditions

  • Nasal Septum Deviation

Sponsors & Collaborators

  • Ankara University

    lead OTHER

Principal Investigators

  • CIGDEM YILDIRIM GUCLU, MD · ANKARA UNIVERSITY FACULTY OF MEDICINE

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2013-01-31
Completion
2013-02-28

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02026999 on ClinicalTrials.gov